{
  "id": "281ece3c943f3d08",
  "title": "Cadonilimab ( PD - 1 / CTLA - 4 ) Receives FDA Clearance for Global Phase III First - Line Gastric Cancer Trial Versus Nivolumab",
  "description": "20251212T033000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/12/tmt-newswire/pr-newswire/cadonilimab-pd-1ctla-4-receives-fda-clearance-for-global-phase-iii-first-line-gastric-cancer-trial-versus-nivolumab/2242164",
  "published_at": "20251212T033000Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/12/tmt-newswire/pr-newswire/cadonilimab-pd-1ctla-4-receives-fda-clearance-for-global-phase-iii-first-line-gastric-cancer-trial-versus-nivolumab/2242164",
    "url_mobile": "https://www.manilatimes.net/2025/12/12/tmt-newswire/pr-newswire/cadonilimab-pd-1ctla-4-receives-fda-clearance-for-global-phase-iii-first-line-gastric-cancer-trial-versus-nivolumab/2242164/amp",
    "title": "Cadonilimab ( PD - 1 / CTLA - 4 ) Receives FDA Clearance for Global Phase III First - Line Gastric Cancer Trial Versus Nivolumab",
    "seendate": "20251212T033000Z",
    "socialimage": "https://www.manilatimes.net/theme_manilatimes/images/TMT_1920x1008.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}